Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method-Experience across the 2010/11 season

Vaccine

Volumn 31, Issue 41, 2013, Pages 4556-4563

  Kavanagh, Kimberley ^a   Robertson, Chris ^a,b,c   McMenamin, Jim ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Seasonal influenza vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; GENERAL PRACTICE; HUMAN; INFANT; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA;

SEASONAL INFLUENZA VACCINE EFFECTIVENESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SCOTLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883598601     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.056     Document Type: Article

References (23)

1. Kavanagh K., Robertson C., McMenamin J. Assessment of the variability in Influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach. PLoS ONE 2011, 6(12):e28743.
2. Valenciano M., Kissling E., Ciancio B.C., Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010, 28:7381-7388.
3. Pebody R., Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveillance 2011, 16(6). pii=19791.
4. Kissling E., Valenciano M. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2011, 16(11). pii=19818.
5. Savulescu C., Jiménez-Jorge S., de Mateo S., Ledesma J., Pozo F., Casas I., et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro Surveillance 2011, 16(11). pii=19820.
6. Castilla J., Moran J., Martinez-Artola V., Reina G., Martinez-Baz I., Garcia Cenoz M., et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveillance 2011, 16(7). pii=19799.
7. Pebody R.G., Andrews N., Fleming D.M., McMenamin J., Cottrell S., Smyth B., et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiology and Infection 2013, 141:620-630.
8. Jiménez-Jorge S., Savulescu C., Pozo F., de Mateo S., Casas I., Ledesma J., et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012, 30(24):3595-3602.
9. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
10. Castilla J., Morán J., Martínez-Artola V., Fernández-Alonso M., Guevara M., Cenoz M.G., et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: Cohort and case-control study. Vaccine 2011, 29(35):5919-5924.
11. Farrington C.P. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993, 22(4):742-746.
12. Frome E.L. The analysis of rates using Poisson regression models. Biometrics 1983, 39:665-674.
13. Cox D.R. Regression models and lifetables. JRSS Series B (Methodological) 1972, 34:187-220.
14. McLoone P. Carstairs Scores; 2004. [accessed 17.06.11]. http://www.sphsu.mrc.ac.uk/publications/carstairs-scores.html.
15. Lone N.I., Simpson C., Kavanagh K., Robertson C., McMenamin J., Ritchie L., et al. Seasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set. BMJ Open 2012, 2(March (2)):e001019. [PMID: 22422920].
16. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 1998, 17:2265-2281.
17. Rosenbaum P.R., Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Society 1984, 79:516-524.
18. Wood S.N. Generalized additive models: an introduction with R 2006, Chapman and Hall/CRC, Boca Raton, FL.
19. R.Development Core Team R: A language and environment for statistical computing 2011, ISBN 3-900051-07-0, R Foundation for Statistical Computing, Vienna, Austria, URL. http://www.r-project.org/.
20. GROS (2012) General Registrar's Office for Scotland, National Records of Scotland; 2012. http://www.gro-scotland.gov.uk/statistics/theme/population/estimates/mid-year/index.html.
21. HPS (2011) Influenza Update Report (Week 13, 2010/11); 2011. http://www.documents.hps.scot.nhs.uk/respiratory/seasonal-influenza/flu-update/2011-04-07.pdf.
22. Pebody R.G., Andrews N., McMenamin J., Dumal H., Ellis J., Thompson C.I., et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Eurosurveillance 2013, 18(5). pii=20389.
23. Valenclano M., Clanclo B.C. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Eurosurveillance 2013, 17(39). pii=20281.